mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 76 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 2,852,805 | 0 | T | G | 51.0% | 48.9 / 78.4 | 51 | V785G (GTT→GGT) | mutS | DNA mismatch repair protein MutS |
| * | NZ_CP009273 | 1,870,272 | 0 | A | G | 38.5% | 53.5 / 13.9 | 39 | I115V (ATT→GTT) | nimT | 2‑nitroimidazole transporter |
| * | NZ_CP009273 | 2,738,448 | 0 | A | C | 38.3% | 85.9 / 14.3 | 47 | V84G (GTG→GGG) | trmD | tRNA (guanosine(37)‑N1)‑methyltransferase TrmD |
| * | NZ_CP009273 | 1,429,984 | 0 | G | A | 36.8% | 59.1 / 18.2 | 38 | intergenic (‑108/+33) | uspF/ompN | universal stress protein UspF/porin OmpN |
| * | NZ_CP009273 | 4,570,447 | 0 | A | T | 34.8% | 82.5 / 18.1 | 46 | L278Q (CTA→CAA) | hsdS | type I restriction‑modification system specificity subunit |
| * | NZ_CP009273 | 3,479,745 | 0 | G | A | 34.7% | 121.5 / 24.5 | 76 | A89A (GCG→GCA) | crp | cAMP‑activated global transcriptional regulator CRP |
| * | NZ_CP009273 | 2,319,929 | 0 | T | G | 34.3% | 65.0 / 11.5 | 35 | G114G (GGT→GGG) | atoB | acetyl‑CoA acetyltransferase |
| * | NZ_CP009273 | 1,429,982 | 0 | C | A | 34.2% | 77.9 / 12.0 | 38 | intergenic (‑106/+35) | uspF/ompN | universal stress protein UspF/porin OmpN |
| * | NZ_CP009273 | 1,429,964 | 0 | C | A | 33.3% | 104.5 / 15.4 | 42 | intergenic (‑88/+53) | uspF/ompN | universal stress protein UspF/porin OmpN |
| * | NZ_CP009273 | 2,476,747 | 0 | T | A | 33.3% | 83.7 / 14.2 | 45 | L24F (TTA→TTT) | emrK | multidrug efflux MFS transporter periplasmic adaptor subunit EmrK |
| * | NZ_CP009273 | 4,570,457 | 0 | C | T | 33.3% | 80.1 / 14.3 | 45 | E275K (GAA→AAA) | hsdS | type I restriction‑modification system specificity subunit |
| * | NZ_CP009273 | 4,333,713 | 0 | A | G | 32.6% | 81.6 / 11.7 | 50 | G176G (GGA→GGG) | melB | melibiose:sodium transporter MelB |
| * | NZ_CP009273 | 1,429,975 | 0 | G | A | 32.4% | 64.3 / 12.8 | 37 | intergenic (‑99/+42) | uspF/ompN | universal stress protein UspF/porin OmpN |
| * | NZ_CP009273 | 1,429,978 | 0 | T | A | 32.4% | 64.4 / 13.4 | 37 | intergenic (‑102/+39) | uspF/ompN | universal stress protein UspF/porin OmpN |
| * | NZ_CP009273 | 4,538,640 | 0 | A | C | 32.2% | 135.1 / 11.4 | 59 | T6P (ACC→CCC) | fimH | type 1 fimbria D‑mannose specific adhesin FimH |
| * | NZ_CP009273 | 3,199,805 | 0 | C | A | 32.1% | 137.8 / 16.6 | 81 | intergenic (‑190/‑17) | ttdR/ttdA | DNA‑binding transcriptional activator TtdR/L(+)‑tartrate dehydratase subunit alpha |
| * | NZ_CP009273 | 782,311 | 0 | A | C | 32.1% | 114.3 / 11.1 | 54 | G247G (GGT→GGG) | gpmA | 2,3‑diphosphoglycerate‑dependent phosphoglycerate mutase |
| * | NZ_CP009273 | 3,659,062 | 0 | C | A | 32.0% | 297.0 / 47.7 | 128 | A37S (GCG→TCG) | gadX | acid resistance transcriptional activator GadX |
| * | NZ_CP009273 | 3,046,944 | 0 | T | G | 31.9% | 92.0 / 10.2 | 47 | N419T (AAC→ACC) | pepP | Xaa‑Pro aminopeptidase |
| * | NZ_CP009273 | 3,171,107 | 0 | C | A | 31.8% | 162.9 / 36.4 | 89 | E55* (GAG→TAG) | nudF | ADP‑ribose diphosphatase |